Rate of Blood Pressure Control Among Hypertensive Patients With Hemodialysis in Sohag University Hospital
NCT ID: NCT06430099
Last Updated: 2024-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
200 participants
OBSERVATIONAL
2024-05-24
2024-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. What is the pattern of blood pressure control among patients receiving hemodialysis?
2. What are factors associated with successful blood pressure control?
3. What is the level of patient knowledge and awareness regarding blood pressure management?
4. What are the challenges and barriers faced by patients in achieving optimal blood pressure control? Participants Blood pressure calculated by taking the average of three consecutive days measurement.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Educational Intervention for Sodium Restriction in Patients With Hypertension
NCT02848690
Phenotyping of the Out-of-proportion Pulmonary Hypertension
NCT06051396
Effect of Plasma Sodium Concentration on Blood Pressure Regulators During Hemodialysis
NCT03578510
Central Hemodynamic and Sodium Urinary
NCT03932422
Blood Pressure Change and Outcome
NCT01330004
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Target Population: Patients undergoing hemodialysis.
3. Sample Size: The target sample size are all hypertensive patients in Sohag university hospital dialysis unit
4. Survey Method: person to person interview in dialysis units will be used for data collection.
Blood pressure calculated by taking the average of three consecutive days
* 1st day (Dialysis Day): - Blood pressure will be measured (pre dialysis, inter dialysis, post dialysis).
* 2nd day (Inter Dialytic Day): - Blood pressure will be measured two times (AM, PM).
* 3rd day (Dialysis Day): - Blood pressure will be measured (pre dialysis, inter dialysis, post dialysis).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years or older.
* currently receiving hemodialysis.
* Hypertensive patients.
Exclusion Criteria
* Patients stopped hemodialysis.
* Patients with ESRD not receiving hemodialysis.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hager Abdo Mohamed
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hager Abdo Mohamed
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hassan A Hassanien, professor
Role: STUDY_CHAIR
Sohag University
Alaa A Ghaleb, professor
Role: STUDY_CHAIR
Sohag University
Ahmed N Nour Eldin, Lecturer
Role: STUDY_CHAIR
Sohag University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine Sohag University
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Susel J, Batycka-Baran A, Reich A, Szepietowski JC. Uraemic pruritus markedly affects the quality of life and depressive symptoms in haemodialysis patients with end-stage renal disease. Acta Derm Venereol. 2014 May;94(3):276-81. doi: 10.2340/00015555-1749.
Lopes AA, Bragg J, Young E, Goodkin D, Mapes D, Combe C, Piera L, Held P, Gillespie B, Port FK; Dialysis Outcomes and Practice Patterns Study (DOPPS). Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int. 2002 Jul;62(1):199-207. doi: 10.1046/j.1523-1755.2002.00411.x.
Joshi VD. Quality of life in end stage renal disease patients. World J Nephrol. 2014 Nov 6;3(4):308-16. doi: 10.5527/wjn.v3.i4.308.
Garcia-Llana H, Remor E, Selgas R. Adherence to treatment, emotional state and quality of life in patients with end-stage renal disease undergoing dialysis. Psicothema. 2013 Feb;25(1):79-86. doi: 10.7334/psicothema2012.96.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Sohagu.
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.